Evidence map›Paper›PMID 37433867›Full record

ArticleNPJ systems biology and applications2023

The Sherpa hypothesis: Phenotype-Preserving Disordered Proteins stabilize the phenotypes of neurons and oligodendrocytes.

Vic Norris, Judit Oláh, Sergey N Krylov, Vladimir N Uversky, Judit Ovádi

Open access · goldAbstract read
In one paragraph

Article in NPJ systems biology and applications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Hunting the Cell CycleLife (Basel, Switzerland) · 2024
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Vic NorrisLaboratory of Microbiology Signals and Microenvironment, University of Rouen, 76821, Mont Saint Aignan, France. victor.norris@univ-rouen.fr.ORCID 0000-0002-1725-7262
Judit OláhInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, H-1117, Hungary.ORCID 0000-0002-2470-8631
Sergey N KrylovCentre for Research on Biomolecular Interactions, York University, Toronto, ON M3J1P3, Canada.
Vladimir N UverskyDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, 33612, USA.ORCID 0000-0002-4037-5857
Judit OvádiInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, H-1117, Hungary.
Institute of Molecular Life Sciences · HUUniversité de Rouen Normandie · FRUniversity of South Florida · USYork University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intrinsically disordered proteins (IDPs), which can interact with many partner proteins, are central to many physiological functions and to various pathologies that include neurodegeneration. Here, we introduce the Sherpa hypothesis, according to which a subset of stable IDPs that we term Phenotype-Preserving Disordered Proteins (PPDP) play a central role in protecting cell phenotypes from perturbations. To illustrate and test this hypothesis, we computer-simulate some salient features of how cells evolve and differentiate in the presence of either a single PPDP or two incompatible PPDPs. We relate this virtual experiment to the pathological interactions between two PPDPs, α-synuclein and Tubulin Polymerization Promoting Protein/p25, in neurodegenerative disorders. Finally, we discuss the implications of the Sherpa hypothesis for aptamer-based therapies of such disorders.

Indexed as

NeuronsOligodendrogliaPhenotypePyrethrinscypermethrinPyrethrins

Identifiers

PMID37433867
PMCPMC10336114
OpenAlexW4383955926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.